References

medsovet

Медицинский Совет

Meditsinskiy sovet = Medical Council

2079-701X2658-5790

REMEDIUM GROUP Ltd.

10.21518/2079-701X-2018-16-72-79

medsovet-2635

Research Article

Сердечная недостаточность

Heart failure

Сердечная недостаточность и синдром старческой астении

Heart failure and senile asthenia syndrome

Котовская

Ю. В.

Kotovskaya

Yu. V.

д.м.н., профессор

Moscow

Розанов

А. В.

Rozanov

A. V.

д.м.н.

Moscow

Курашев

Д. Х.

Kurashev

D. H.

Moscow

Ткачева

О Н.

Tkacheva

O. N.

д.м.н., профессор

Moscow

Российский геронтологический научно-клинический центр ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава РоссииРоссияRussian Scientific and Clinical Center of Gerontology, Pirogov Russian National Research Medical University of the Ministry of Health of RussiaRussian Federation

2018

27092018

0167279

2018

Котовская Ю.В., Розанов А.В., Курашев Д.Х., Ткачева О.Н.

Kotovskaya Y.V., Rozanov A.V., Kurashev D.H., Tkacheva O.N.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.med-sovet.pro/jour/article/view/2635

Принимая во внимание рост возраста пациентов с сердечной недостаточностью (СН), растет роль специфических подходов к их ведению, поскольку у пациентов этого возраста необходимо внимание к гериатрическим проблемам: снижению мобильности, множественным заболеваниям и когнитивным нарушениям. Старческая астения – синдром, отражающий снижение физиологического резерва организма и его уязвимость к воздействию различных стрессорных факторов. Старческая астения выявляется у 15–74% пациентов с СН, распространенность зависит от метода диагностики и изучаемой популяции. В представленном обзоре рассматривается влияние старческой астении, коморбидности и гериатрических синдромов на диагностику, лечение и исходы у пожилых пациентов с СН. Выявление старческой астении у пациентов с СН важно с клинической точки зрения, поскольку это состояние оказывает неблагоприятное влияние на течение СН и ассоциировано с большей частотой неотложной госпитализации и смертности. Физические упражнения могут улучшить мобильность, а введение сестринского наблюдения может способствовать повышению приверженности пациентов к лечению.

The role of specific approaches to the management of patients with heart failure (HF) increases steeply with increasing age, as the patients of this age need attention to geriatric problems: reduced mobility, multiple diseases and cognitive impairment. Senile asthenia is a syndrome that reflects a decline in physiological reserve and increased vulnerability to various stressors. Senile asthenia is detected in 15–74% of patients with heart failure, the prevalence depends on the method of diagnosis and the studied population. This review discusses the effects of senile asthenia, comorbidity and geriatric syndromes on diagnosis, treatment, and outcomes in elderly patients with heart failure. The detection of senile asthenia in patients with HF is important from a clinical point of view, since this condition has an adverse effect on the course of heart failure and is associated with a higher incidence of emergency hospitalization and mortality. Bodily exercises can improve mobility, and the introduction of nursing observation can enhance treatment adherence among patients.

сердечная недостаточностьстарческая астениясаркопения

heart failuresenile astheniasarcopenia

References1

Мареев В.Ю., Фомин И.В., Агеев Ф.Т., Арутюнов Г.П., Беграмбекова Ю.Л., Беленков Ю.Н. и др. Клинические рекомендации. Хроническая сердечная недостаточность (ХСН). Журнал Сердечная Недостаточность. 2017, 18(1): 3–40. doi: 10.18087/rhfj.2017.1.2346.

Mareev VYu., Fomin IV, Ageev FT, Arutyunov GP, Beggrambekova YuL., Belenkov YuN, et al. Clinical practice guidelines. Chronic heart failure (CHF). Zhurnal Serdechnaya Nedostatochnost. 2017, 18 (1): 3-40. doi: 10.18087/rhfj.2017.1.2346.

Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M et al. American Heart Association Statistics Committee, Stroke Statistics Subcommittee. Executive Summary: Heart Disease and Stroke Statistics–2016 Update: A Report From the American Heart Association. Circulation, 2016, 133(4): 447-54. doi: 10.1161/CIR.0000000000000366.

Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал, 2016, (8): 7–13. doi: 10.15829/1560-4071-2016-8-7-13.

Fomin IV. Chronic heart failure in the Russian Federation: what we know today and what should be done. Rossiyskiy Kardiologicheskiy Zhurnal, 2016, (8): 7-13. doi: 10.15829/1560-4071-2016-8-7-13.

Chaudhry SI, Wang Y, Gill TM, Krumholz HM. Geriatric conditions and subsequent mortality in older patients with heart failure. J Am Coll Cardiol, 2010, 55: 309–16.

Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, et al. Frailty consensus: a call to action. J Am Med Dir Assoc, 2013, 14: 392–7.

Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol, 2014, 63: 747–62.

Ткачева О.Н., Котовская Ю.В., Остапенко В.С. Особенности клинических подходов к ведению пациентов со старческой астенией. РМЖ, 2017, 25(25): 1823-1825.

Tkacheva ON, Kotovskaya YuV, Ostapenko VS. Features of clinical approaches to the management of patients with senile asthenia. BC, 2017, 25 (25): 1823-1825.

McNallan SM, Chamberlain AM, Gerber Y, Singh M, Kane RL, Weston SA, et al. Measuring frailty in heart failure: a community perspective. Am Heart J, 2013, 166: 768–74.

Uchmanowicz I, Łoboz-Rudnicka M, Szeląg P, Jankowska-Polańska B, Łoboz-Grudzień K. Frailty in Heart Failure. Curr Heart Fail Rep, 2014, 11(3): 266-73. doi: 10.1007/s11897-014- 0198-4.

Uchmanowicz I, Łoboz-Rudnicka M, Szeląg P, Jankowska-Polańska B, Łoboz-Grudzień K. Frailty in Heart Failure. Curr Heart Fail Rep, 2014, 11(3): 266-73. doi: 10.1007/s11897-014-0198-4.

Kleipool EE, Hoogendijk EO, Trappenburg MC, Handoko ML, Huisman M, Peters MJ, Muller M. Frailty in Older Adults with Cardiovascular Disease: Cause, Effect or Both? Aging Dis, 2018, 9(3): 489-497. doi: 10.14336/ AD.2017.1125.

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci, 2001, 56: M146–56.

Ткачева О.Н., Рунихина Н.К., Остапенко В.С. и соавт. Валидация опросника для скрининга синдрома старческой астении в амбулаторной практике. Успехи геронтологии, 2017, 2: 236-242.

Tkacheva ON, Runikhina NK, Ostapenko VS, et al. Validation of the senile asthenia syndrome questionnaire in outpatient practice. Uspekhi Gerontologii, 2017, 2: 236-242

http://www.eugms.org/news/read/article/374.html.

Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci, 2007, 62: 738–43.

Altimir S, Lupon J,Gonzalez B, Prats M, Parajon T, UrrutiaA, et al. Sex and age differences in fragility in a heart failure population. Eur J Heart Fail, 2005, 7: 798–802.

Khan H, Kalogeropoulos AP, Georgiopoulou VV, Newman AB, Harris TB, Rodondi N, et al. Frailty and risk for heart failure in older adults: the health, aging, and body composition study. Am Heart J, 2013, 166: 887–94.

Newman AB, Gottdiener JS, McBurnie MA, Hirsch CH, Kop WJ, Tracy R, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci, 2001, 56: M158–66.

Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, et al. Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc, 2005, 53: 1321–30.

Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med, 2009, 360: 1418–28.

Braunstein JB, Anderson GF, Gerstenblith G,WellerW, Niefeld M, Herbert R, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol, 2003, 42: 1226–33.

Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med, 2002, 162: 2333–41.

Cacciatore F, Abete P, Mazzella F, Viati L, Della Morte D, D’Ambrosio D, et al. Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur J Clin Investig, 2005, 35: 723–30.

Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci, 2009, 64: 1183–9.

Chang SS, Weiss CO, Xue QL, Fried LP. Association between inflammatory-related disease burden and frailty: results from the Women’s Health and Aging Studies (WHAS) I and II. Arch Gerontol Geriatr, 2012, 54: 9–15.

Alonso-Bouzon C, Carcaillon L, Garcia-Garcia FJ, Amor-Andres MS, El Assar M, Rodriguez-Manas L. Association between endothelial dysfunction and frailty: the Toledo Study for Healthy Aging. Age, 2013, 20: 20.

Varadhan R, Chaves PH, Lipsitz LA, Stein PK, Tian J, Windham BG, et al. Frailty and impaired cardiac autonomic control: new insights from principal components aggregation of traditional heart rate variability indices. J Gerontol A Biol Sci Med Sci, 2009, 64: 682–7.

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the EuropeanWorking Group on Sarcopenia in Older People. Age Ageing, 2010, 39: 412–23.

Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol, 1998, 147: 755–63.

Landi F, Cruz-Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M, et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing, 2013, 42: 203–9.

Fulster S, Tacke M, Sandek A, Ebner N, Tschope C, Doehner W, et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J, 2013, 34: 512–9.

Pureza V, Florea VG. Mechanisms for cachexia in heart failure. Curr Heart Fail Rep, 2013, 10: 307–14.

Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr, 2008, 27: 793–9.

Anker SD, Laviano A, Filippatos G, John M, Paccagnella A, Ponikowski P, et al. ESPEN guidelines on parenteral nutrition: on cardiology and pneumology. Clin Nutr, 2009, 28: 455–60.

Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet, 1997, 349: 1050–3.

Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging, 2009, 13: 460–6.

Ather S, ChanW, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol, 2012, 59: 998–1005.

Wong CH, Weiss D, Sourial N, Karunananthan S, Quail JM, Wolfson C, et al. Frailty and its association with disability and comorbidity in a community-dwelling sample of seniors in Montreal: a cross-sectional study. Aging Clin Exp Res, 2010, 22: 54–62.

Kelaiditi E, Cesari M, Canevelli M, van Kan GA, Ousset PJ, Gillette-Guyonnet S, et al. Cognitive frailty: rational and definition from an (I.A.N.A./ I.A.G.G.) international consensus group. J Nutr Health Aging, 2013, 17: 726–34.

Nguyen HT, Black SA, Ray LA, Espino DV, Markides KS. Cognitive impairment and mortality in older mexican americans. J Am Geriatr Soc, 2003, 51: 178–83.

Zuccala G, Marzetti E, Cesari M, Lo Monaco MR, Antonica L, Cocchi A, et al. Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey. Am J Med, 2005, 118: 496–502.

Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail, 2007, 9: 440–9.

Laurence BD, Michel L. The Fall in Older Adults: Physical and Cognitive Problems. Curr Aging Sci, 2017, 10(3): 185-200.

Persad CC, Jones JL, Ashton-Miller JA, Alexander NB, Giordani B. Executive function and gait in older adults with cognitive impairment. J Gerontol A Biol Sci Med Sci, 2008, 63: 1350–5.

Murad K, Kitzman DW. Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management. Heart Fail Rev, 2012, 17: 581–8

Орлова Я.А., Ткачева О.Н., Арутюнов Г.П., Котовская Ю.В. Особенности диагностики и лечения хронической сердечной недостаточности у пациентов пожилого и старческого возраста. Мнение экспертов Общества специалистов по сердечной недостаточности, Российской ассоциации геронтологов и гериатров и Евразийской ассоциации терапевтов. Журнал Сердечная недостаточность, 2018 (в печати).

Orlova YaA, Tkacheva ON, Arutyunov GP, Kotovskaya YuV. Features of diagnosis and treatment of chronic heart failure in elderly and senile patients. Opinion of the experts of the Heart Failure Association, the Russian Association of Gerontologists and Geriatrics and the Eurasian Association of Therapists. Zhurnal Serdechnaya Nedostatochnost, 2018 (in print).

Manzano L, Escobar C, Cleland JG, Flather M. Diagnosis of elderly patients with heart failure. Eur J Heart Fail, 2012, 14: 1097–103.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH van der MPAFMDR. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J, 2016. 37: 2129-200. doi: 10.1002/ejhf.592.

Ткачева О.Н., Рунихина Н.К., Воробьева Н.М., Комаров А.Л., Котовская Ю.В., Панченко Е.П., Плохова Е.В., Фролова Е.В., Явелов И.С. Антитромботическая терапия в пожилом и старческом возрасте: согласованное мнение экспертов. Кардиоваскулярная терапия и профилактика, 2017, 16(3): 4-33.

Tkacheva ON, Runikhina NK, Vorobyova NM, Komarov AL, Kotovskaya YuV., Panchenko EP, Plokhova EV, Frolova EV, Yavelov IS. Antithrombotic therapy in elderly and senile age: formal consensus of experts. Kardiovaskulyarnaya Terapiya i Profilaktika, 2017, 16 (3): 4-33.

Сычев Д.А., Жучков А.В., Богова О.Т., Ильина Е.С. Падения пациентов пожилого и старческого возраста: вклад лекарственных средств. Клиническая геронтология, 2017, 23(3-4): 56-64.

Sychev DA, Zhuchkov AV, Bogova OT, Ilyina ES. Falls of elderly and senile patients: contribution of medicines. Klinicheskaya Gerontologiya, 2017, 23 (3-4): 56-64.

Орлова Я.А. Особенности физической реабилитации пожилых пациентов с ХСН. Журнал сердечная недостаточность, 2016, 17(5): 365-375.

Orlova YaA. Features of physical rehabilitation of elderly patients with CHF. Zhurnal Serdechnaya Nedostatochnost, 2016, 17 (5): 365-375.

Boxer RS, Dauser DA, Walsh SJ, Hager WD, Kenny AM. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc, 2008, 56: 454–61.

Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, ZhangY, Karlson EW, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr., 2004, 80: 752–8.

The authors declare that there are no conflicts of interest present.